CD8A and neoplasm: Recently, Zou and collaborators have shown that tumor cells disrupt methionine metabolism in CD8+ T cells, leading to lower intracellular levels of methionine and the methyl donor S-adenosylmethionine (SAM), resulting in loss of H3K79me2 in these T cells [241].